Optimizing treatment outcomes in patients with schizophrenia
Dr Andreas Schreiner is a certified psychiatrist and neurologist who currently holds the position of Vice President Medical & Scientific Affairs CNS and Internal Medicine at Janssen-Cilag Europe, Middle East and Africa.
Dr Schreiner studied medicine at the Universities of Heidelberg and Mannheim, Germany, and completed residencies in the Department of Neurology at the University Hospital in Mannheim and in Psychiatry at the Central Institute of Mental Health Mannheim, University of Heidelberg. He joined Janssen-Cilag Medical & Scientific Affairs in 1999.
Dr Schreiner is frequently lecturing and has given more than 500 scientific presentations at national and international meetings. He has also published more than 50 peer-reviewed manuscripts in national and international journals, has written several book chapters and has presented more than 300 abstracts at national and international meetings. Dr Schreiner is a member of many scientific associations including the Schizophrenia International Research Society (SIRS), the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) the American Academy of Neurology (AAN) and the American Epilepsy Society (AES).